These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 37868419)

  • 1. Is Artificial Intelligence the Cost-Saving Lens to Diabetic Retinopathy Screening in Low- and Middle-Income Countries?
    Rizvi A; Rizvi F; Lalakia P; Hyman L; Frasso R; Sztandera L; Das AV
    Cureus; 2023 Sep; 15(9):e45539. PubMed ID: 37868419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
    Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H
    JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial intelligence for telemedicine diabetic retinopathy screening: a review.
    Nakayama LF; Zago Ribeiro L; Novaes F; Miyawaki IA; Miyawaki AE; de Oliveira JAE; Oliveira T; Malerbi FK; Regatieri CVS; Celi LA; Silva PS
    Ann Med; 2023; 55(2):2258149. PubMed ID: 37734417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic Evaluations and Equity in the Use of Artificial Intelligence in Imaging Exams for Medical Diagnosis in People With Skin, Neurological, and Pulmonary Diseases: Protocol for a Systematic Review.
    Santana GO; Couto RM; Loureiro RM; Furriel BCRS; Rother ET; de Paiva JPQ; Correia LR
    JMIR Res Protoc; 2023 Dec; 12():e48544. PubMed ID: 38153775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Artificial Intelligence Algorithms for Diabetic Retinopathy Detection: Protocol for a Systematic Review and Meta-Analysis.
    Sesgundo Iii JA; Maeng DC; Tukay JA; Ascano MP; Suba-Cohen J; Sampang V
    JMIR Res Protoc; 2024 May; 13():e57292. PubMed ID: 38801771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial intelligence technologies and compassion in healthcare: A systematic scoping review.
    Morrow E; Zidaru T; Ross F; Mason C; Patel KD; Ream M; Stockley R
    Front Psychol; 2022; 13():971044. PubMed ID: 36733854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial intelligence for diabetic retinopathy in low-income and middle-income countries: a scoping review.
    Cleland CR; Rwiza J; Evans JR; Gordon I; MacLeod D; Burton MJ; Bascaran C
    BMJ Open Diabetes Res Care; 2023 Aug; 11(4):. PubMed ID: 37532460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion of diabetic retinopathy screening strategies in national-level diabetes care planning in low-income and middle-income settings: protocol for a scoping review.
    Curran K; Piyasena P; Congdon N; Duke L; Malanda B; Peto T
    BMJ Open; 2020 Sep; 10(9):e038647. PubMed ID: 32948570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
    Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
    BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population impact and cost-effectiveness of artificial intelligence-based diabetic retinopathy screening in people living with diabetes in Australia: a cost effectiveness analysis.
    Hu W; Joseph S; Li R; Woods E; Sun J; Shen M; Jan CL; Zhu Z; He M; Zhang L
    EClinicalMedicine; 2024 Jan; 67():102387. PubMed ID: 38314061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are current clinical studies on artificial intelligence-based medical devices comprehensive enough to support a full health technology assessment? A systematic review.
    Farah L; Davaze-Schneider J; Martin T; Nguyen P; Borget I; Martelli N
    Artif Intell Med; 2023 Jun; 140():102547. PubMed ID: 37210155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Economic Analysis for the Use of Artificial Intelligence in Screening for Diabetic Retinopathy in Trinidad and Tobago.
    Ramoutar RR
    Cureus; 2024 Mar; 16(3):e55745. PubMed ID: 38586698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Economic Implications of Artificial Intelligence Implementation for Ophthalmology in Australia: A Systematic Review.
    Pietris J; Lam A; Bacchi S; Gupta AK; Kovoor JG; Chan WO
    Asia Pac J Ophthalmol (Phila); 2022 Nov; 11(6):554-562. PubMed ID: 36218837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review of Health Economic Evaluations Focused on Artificial Intelligence in Healthcare: The Tortoise and the Cheetah.
    Voets MM; Veltman J; Slump CH; Siesling S; Koffijberg H
    Value Health; 2022 Mar; 25(3):340-349. PubMed ID: 35227444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public stewardship of private for-profit healthcare providers in low- and middle-income countries.
    Wiysonge CS; Abdullahi LH; Ndze VN; Hussey GD
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD009855. PubMed ID: 27510030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
    Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J
    PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of diabetic retinopathy screening programs using telemedicine: a systematic review.
    Avidor D; Loewenstein A; Waisbourd M; Nutman A
    Cost Eff Resour Alloc; 2020; 18():16. PubMed ID: 32280309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.